Cellular and humoral immunity towards parental SARS-CoV-2 and variants of concern after two doses of the NVX-CoV2373-vaccine in comparison to homologous BNT162b and mRNA1273 regimens

Franziska Hielscher, Tina Schmidt, Verena Klemis, Alexander Wilhelm, Stefanie Marx, Amina Abu-Omar, Laura Ziegler, Candida Guckelmus, Rebecca Urschel, Urban Sester, Marek Widera, Martina Sester
doi: https://doi.org/10.1101/2022.08.02.22278342

Data Availability

All figures and tables have associated raw data. The data that support the findings of this study are available from the corresponding author upon request.

Back to top
Posted August 03, 2022.
Download PDF
Data/Code
Email
Cellular and humoral immunity towards parental SARS-CoV-2 and variants of concern after two doses of the NVX-CoV2373-vaccine in comparison to homologous BNT162b and mRNA1273 regimens
Franziska Hielscher, Tina Schmidt, Verena Klemis, Alexander Wilhelm, Stefanie Marx, Amina Abu-Omar, Laura Ziegler, Candida Guckelmus, Rebecca Urschel, Urban Sester, Marek Widera, Martina Sester
medRxiv 2022.08.02.22278342; doi: https://doi.org/10.1101/2022.08.02.22278342
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area